Nr 546 week 5 table - Study guides, Class notes & Summaries

NR 546 Week 5 Antidepressant and Mood Stabilizer Medication Table latest update 2024 GRADED A+

NR 546 Week 5 Antidepressant and Mood Stabilizer Medication Table-2023

NR 546 Week 8 Neurotransmitter Table Chamberlain College Of Nursing. MNDA N-methyl-D-aspartate (NMDA) receptors represent one of the ligand-gated non-selective ionotropic glutamate receptors (iGluRs), which CNS NMDA receptors are found in both synaptic and extrasynaptic NDMA Glutamate Antagonist NDMA Glutamate AntagonistMemantine Phencyclidine Ketamine Dextromethorphan Dextromethadone are present in high density within the hippocampus and the cerebral cortex N-methyl-D-aspa...

NR 546 Week 5 Antidepressant and Mood Stabilizer Medication Table latest update 2024 GRADED A+

NR 546 Week 5 Antidepressant and Mood Stabilizer Medication Table latest update 2024 GRADED A+ Antidepressant Medications Name Indication, starting dose, target symptoms, and affected neurotransmitters Half-life (T1/2) CYP450 enzyme Notes/Notable side effects/Precautions SSRIs Citalopram (Celexa) Selective serotonin reuptake inhibitor Commonly prescribed for depression, PMDD, OCD, panic disorder, GAD, PTSD, social anxiety disorder Starting dose: 20mg/day Blocks serotonin and serot...

NR 546 Week 5 Antidepressant and Mood Stabilizer Medication Table-2023

NR 546 Week 8 Neurotransmitter Table Chamberlain. Neuro transmitter Receptor Subtype Location/Function/Effects /symptoms of excess or deficit if applicable Distribution (ie: CNS/PNS, GI, vascular) Drug classes that target this neurotransmitter or receptor Specific medications that target this neurotransmitter or receptor Glutamate AMPA α-Amino-3-hydroxy-5- methyl-4- isoxazolepropionic acid (AMPA)-type glutamate receptors (AMPARs) mediate the majority of fast excitatory syn...

NR 546 Week 5 Antidepressant and Mood Stabilizer Medication Table latest update 2024 GRADED A+

NR 546 Week 7 ADHD Medication Table / NR 546 Week 7 ADHD Medication Table Latest UPDATE 2024 GRADED A+. Drug Name (include if IR, XR, ODT, LA) Indication (include approved ages) Neurotransmitter(s) Affected Target Symptoms Short-acting, intermediate-acting or long-acting. Duration of action, peak (if noted) Notable side effects /Patient education instructions Methylphenidate (D/L) (Concerta, Ritalin) Indication (include approved ages) Attention deficit hyperactivity disord...